Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Dobenecker MW"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dobenecker MW; Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, NY, USA.; Bristol-Meyers Squibb, Princeton, NJ, USA., Marcello J; Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, NY, USA., Becker A; Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, NY, USA.; Departments of Pediatrics, Cell and Developmental Biology, Weill Cornell Medical College, New York, NY, USA., Rudensky E; Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, NY, USA.; NYU Langone Medical Center and School of Medicine, New York, NY, USA., Bhanu NV; Penn Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Carrol T; Bioinformatics Resource Center, Rockefeller University, New York, NY, USA., Garcia BA; Penn Epigenetics Institute, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Prinjha R; Epinova DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline R&D, Stevenage, UK., Yurchenko V; Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, NY, USA.; Sechenov First Moscow State Medical University, Moscow, Russia.; Life Science Research Centre, University of Ostrava, Ostrava, Czech Republic., Tarakhovsky A; Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, NY, USA.
Publikováno v:
FEBS letters [FEBS Lett] 2020 Oct; Vol. 594 (20), pp. 3324-3337. Date of Electronic Publication: 2020 Aug 29.
Autor:
Lee CH; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA., Holder M; Skirball Institute of Biomolecular Medicine, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA., Grau D; Skirball Institute of Biomolecular Medicine, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA., Saldaña-Meyer R; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA., Yu JR; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA., Ganai RA; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA., Zhang J; Skirball Institute of Biomolecular Medicine, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA., Wang M; Skirball Institute of Biomolecular Medicine, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA., LeRoy G; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA., Dobenecker MW; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065, USA., Reinberg D; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: danny.reinberg@nyumc.org., Armache KJ; Skirball Institute of Biomolecular Medicine, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA. Electronic address: karim-jean.armache@med.nyu.edu.
Publikováno v:
Molecular cell [Mol Cell] 2018 May 03; Vol. 70 (3), pp. 435-448.e5. Date of Electronic Publication: 2018 Apr 19.
Autor:
Dobenecker MW; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY dobenem@rockefeller.edu., Park JS; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY., Marcello J; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY.; Now, Faculty of Biology, University of Freiburg, Freiburg, Germany., McCabe MT; Epigenetics Discovery Performance Unit, Oncology R&D, GlaxoSmithKline, Collegeville, PA., Gregory R; Epigenetics Discovery Performance Unit, Immuno-Inflammation TA, Medicines Research Centre, GlaxoSmithKline Research and Development, Stevenage, England, UK., Knight SD; Epigenetics Discovery Performance Unit, Oncology R&D, GlaxoSmithKline, Collegeville, PA., Rioja I; Epigenetics Discovery Performance Unit, Immuno-Inflammation TA, Medicines Research Centre, GlaxoSmithKline Research and Development, Stevenage, England, UK., Bassil AK; Epigenetics Discovery Performance Unit, Immuno-Inflammation TA, Medicines Research Centre, GlaxoSmithKline Research and Development, Stevenage, England, UK., Prinjha RK; Epigenetics Discovery Performance Unit, Immuno-Inflammation TA, Medicines Research Centre, GlaxoSmithKline Research and Development, Stevenage, England, UK., Tarakhovsky A; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY tarakho@rockefeller.edu.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2018 Apr 02; Vol. 215 (4), pp. 1101-1113. Date of Electronic Publication: 2018 Mar 09.
Autor:
Hobeika E; Max-Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany Department of Molecular Immunology, BioIII, Faculty of Biology, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany hobeika@ie-freiburg.mpg.de michael.reth@bioss.uni-freiburg.de., Levit-Zerdoun E; Max-Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany., Anastasopoulou V; Institute of Immunology, Charité Campus Buch, Berlin, Germany., Pohlmeyer R; Max-Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany., Altmeier S; Institute of Mircobiology, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland., Alsadeq A; Department of General Pediatrics, University Medical Center Schleswig-Holstein, Kiel, Germany., Dobenecker MW; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY, USA., Pelanda R; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA., Reth M; Max-Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany Department of Molecular Immunology, BioIII, Faculty of Biology, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany BIOSS, Centre For Biological Signaling Studies, University of Freiburg, Freiburg, Germany hobeika@ie-freiburg.mpg.de michael.reth@bioss.uni-freiburg.de.
Publikováno v:
The EMBO journal [EMBO J] 2015 Apr 01; Vol. 34 (7), pp. 925-39. Date of Electronic Publication: 2015 Jan 28.
Autor:
Dobenecker MW; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065 dobenem@rockefeller.edu tarakho@rockefeller.edu., Kim JK; Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892., Marcello J; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065., Fang TC; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065., Prinjha R; Epinova DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline R&D, Medicines Research Centre, Stevenage SG1 2NY, England, UK., Bosselut R; Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892., Tarakhovsky A; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065 dobenem@rockefeller.edu tarakho@rockefeller.edu.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2015 Mar 09; Vol. 212 (3), pp. 297-306. Date of Electronic Publication: 2015 Feb 16.
Autor:
Delgado-Olguín P; Gladstone Institute of Cardiovascular Disease, and Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA Program in Physiology and Experimental Medicine, The Hospital for Sick Children, Toronto, Ontario M5G0A4, Canada Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada Heart and Stroke Richard Lewar Centre of Excellence, Toronto, Ontario M5G 1L7, Canada paul.delgadoolguin@sickkids.ca bbruneau@gladstone.ucsf.edu., Dang LT; Heart and Stroke Richard Lewar Centre of Excellence, Toronto, Ontario M5G 1L7, Canada Toronto General Research Institute, University Health Network, Toronto, Ontario M5G 1L7, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A1, Canada., He D; Gladstone Institute of Cardiovascular Disease, and Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA., Thomas S; Gladstone Institute of Cardiovascular Disease, and Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA., Chi L; Program in Physiology and Experimental Medicine, The Hospital for Sick Children, Toronto, Ontario M5G0A4, Canada., Sukonnik T; Gladstone Institute of Cardiovascular Disease, and Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA., Khyzha N; Heart and Stroke Richard Lewar Centre of Excellence, Toronto, Ontario M5G 1L7, Canada Toronto General Research Institute, University Health Network, Toronto, Ontario M5G 1L7, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A1, Canada., Dobenecker MW; Laboratory of Lymphocyte Signaling, The Rockefeller University, New York, NY 10021, USA., Fish JE; Heart and Stroke Richard Lewar Centre of Excellence, Toronto, Ontario M5G 1L7, Canada Toronto General Research Institute, University Health Network, Toronto, Ontario M5G 1L7, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A1, Canada., Bruneau BG; Gladstone Institute of Cardiovascular Disease, and Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA Department of Pediatrics, Cardiovascular Research Institute, and Institute for Regeneration Medicine, University of California San Francisco, San Francisco, CA 94158, USA paul.delgadoolguin@sickkids.ca bbruneau@gladstone.ucsf.edu.
Publikováno v:
Development (Cambridge, England) [Development] 2014 Dec; Vol. 141 (23), pp. 4610-7. Date of Electronic Publication: 2014 Oct 30.
Autor:
Tanaka H; Institute for Protein Research, Osaka University, 3-2 Yamada-oka, Suita, Osaka 565-0871, Japan., Akagi K, Oneyama C, Tanaka M, Sasaki Y, Kanou T, Lee YH, Yokogawa D, Dobenecker MW, Nakagawa A, Okada M, Ikegami T
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2013 May 24; Vol. 288 (21), pp. 15240-54. Date of Electronic Publication: 2013 Apr 02.
Autor:
Donlin LT; Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065, USA., Andresen C, Just S, Rudensky E, Pappas CT, Kruger M, Jacobs EY, Unger A, Zieseniss A, Dobenecker MW, Voelkel T, Chait BT, Gregorio CC, Rottbauer W, Tarakhovsky A, Linke WA
Publikováno v:
Genes & development [Genes Dev] 2012 Jan 15; Vol. 26 (2), pp. 114-9. Date of Electronic Publication: 2012 Jan 12.